Results 171 to 180 of about 1,159,378 (230)

The other immune landscape of SARS-CoV-2 evolution. [PDF]

Proc Natl Acad Sci U S A
Ghafari M.
europepmc   +1 more source

National HBsAb serosurvey and HBsAg/Hepatitis D coinfection prevalence across sociodemographic and immigrant populations in Israel. [PDF]

BMC Infect Dis
Yael G, Keren A, Lital KB, Shoshana AS, Orit P, Orna M, Ravit B.   +6 more
europepmc   +1 more source

Preclinical Evaluation of a Microneedle-Delivered Adjuvanted Microparticulate Gonorrhea Vaccine in Non-Human Primates. [PDF]

Vaccines (Basel)
Ferguson A, Harsoda Y, Pasupuleti D, Arte TM, Bagwe P, Gulani M, Adediran E, Uddin M, Petrovsky N, D'Souza MJ, Zughaier SM.   +10 more
europepmc   +1 more source

Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. [PDF]

Sci Rep
Gnouamozi GE, Kooij AC, Schrimpf MR, Zehnder B, Zhang Z, Urban S.   +5 more
europepmc   +1 more source

Antikörper gegen Hepatitis-Delta-Virus-Antigen [PDF]

, 2019
openaire   +1 more source

Analysis of a PCORnet^® database identifies multi-level predictors of delta hepatitis in a U.S. hotspot. [PDF]

Commun Med (Lond)
Alpert L, Zhang X, Smith R, Lange M, Kushner T.   +4 more
europepmc   +1 more source

Viral coinfections and checkpoint-marker expression in HIV: An exploratory HCV-Related CD4⁺ T-Cell PD-L1 pattern. [PDF]

Immunol Res
Aksak-Wąs B, Skonieczna-Żydecka K, Cembrowska-Lech D, Parczewski M, Hrynkiewicz R, Lewandowski F, Serwin K, Mielczak K, Bruss M, Lenkiewicz F, Niedźwiedzka-Rystwej P.   +10 more
europepmc   +1 more source

Resolution of Hepatitis Delta Virus-Related Cryoglobulinemic Vasculitis With the Use of Bulevirtide. [PDF]

ACG Case Rep J
Geremicca G, Labanca S, Pasta A, Pieri G, Marenco S, Cariati S, Grossi A, Giannini EG.   +7 more
europepmc   +1 more source